PI3K/AKT/mTOR inhibitors in combination with ionizing radiation increase the radiosensitivity of malignant cells to radiation activating autophagy and represent a therapeutic approach of radiochemotherapy in GBM patients40–42. This evidence concerns the gene AKT1 and glioblastoma.